This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Prime Pharm Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hoon-Sik Cho: Innovator in Glycosylated Immunoglobulin Technology
Introduction
Hoon-Sik Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of glycosylated immunoglobulins. His innovative work has the potential to impact various therapeutic applications.
Latest Patents
Hoon-Sik Cho holds a patent for a glycosylated immunoglobulin and immunoadhesin comprising the same. The patent describes a glycosylated immunoglobulin or a fragment thereof, which includes an immunoglobulin variant with specific amino acid modifications. This invention also covers a glycosylated fusion protein formed by linking a glycosylated immunoglobulin with at least one biologically active protein. The patent outlines methods for preparing this fusion protein and its potential use in pharmaceutical compositions.
Career Highlights
Hoon-Sik Cho is associated with Korea Prime Pharm Co., Ltd., where he continues to advance his research and development efforts. His work focuses on enhancing the efficacy of immunoglobulins through glycosylation, which can improve their therapeutic properties.
Collaborations
Hoon-Sik Cho has collaborated with notable colleagues in his field, including Yong-Hoon Chung and Ki-Wan Yi. These collaborations have contributed to the advancement of research in glycosylated proteins and their applications.
Conclusion
Hoon-Sik Cho's innovative contributions to glycosylated immunoglobulin technology highlight his role as a key inventor in the biotechnology sector. His patent and ongoing research efforts are poised to make a significant impact in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile